Shenzhen Chipscreen Biosciences Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 276.55 million compared to CNY 186.09 million a year ago. Revenue was CNY 276.55 million compared to CNY 186.09 million a year ago. Net loss was CNY 24.25 million compared to net income of CNY 38.43 million a year ago. Basic loss per share from continuing operations was CNY 0.0591 compared to basic earnings per share from continuing operations of CNY 0.0937 a year ago. Diluted loss per share from continuing operations was CNY 0.0591 compared to diluted earnings per share from continuing operations of CNY 0.0937 a year ago.